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AMACO Is a Component of the Basement Membrane–
Associated Fraser Complex
Rebecca J. Richardson1,2,7, Jan M. Gebauer3, Jin-Li Zhang1,2,8, Birgit Kobbe3, Douglas R. Keene4,
Kristina Rkenes Karlsen5, Stefaˆnia Richetti1, Alexander P. Wohl3, Gerhard Sengle3, Wolfram F. Neiss5,
Mats Paulsson2,3,6, Matthias Hammerschmidt1,2,6 and Raimund Wagener2,3
Fraser syndrome (FS) is a phenotypically variable, autosomal recessive disorder characterized by cryptophthal-
mus, cutaneous syndactyly, and other malformations resulting from mutations in FRAS1, FREM2, and GRIP1.
Transient embryonic epidermal blistering causes the characteristic defects of the disorder. Fras1, Frem1, and
Frem2 form the extracellular Fraser complex, which is believed to stabilize the basement membrane. However,
several cases of FS could not be attributed to mutations in FRAS1, FREM2, or GRIP1, and FS displays high clinical
variability, suggesting that there is an additional genetic, possibly modifying contribution to this disorder. An
extracellular matrix protein containing VWA-like domains related to those in matrilins and collagens (AMACO),
encoded by the VWA2 gene, has a very similar tissue distribution to the Fraser complex proteins in both mouse
and zebrafish. Here, we show that AMACO deposition is lost in Fras1-deficient zebrafish and mice and that Fras1
and AMACO interact directly via their chondroitin sulfate proteoglycan (CSPG) and P2 domains. Knockdown of
vwa2, which alone causes no phenotype, enhances the phenotype of hypomorphic Fras1 mutant zebrafish.
Together, our data suggest that AMACO represents a member of the Fraser complex.
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INTRODUCTION
Fraser syndrome (FS; OMIM #219000) is a rare, autosomal
recessive disorder characterized by cryptophthalmus, cutaneous
syndactyly, and variable other malformations (Slavotinek and
Tifft, 2002). Both the human syndrome and the closely related
bleb mouse phenotype are caused by mutations in genes
encoding proteins of the extracellular Fraser complex, FRAS1,
FREM2, and, in mice, Frem1 (McGregor et al., 2003; Jadeja
et al., 2005). The ectodomain of Fras1 is shed from the cell
surface and forms a ternary complex with Frem1 and Frem2,
which reciprocally stabilize each other at the basement
membrane (BM; Kiyozumi et al., 2006). The proteins are
characterized by the shared presence of 12 chondroitin
sulfate proteoglycan (CSPG) repeats and single or multiple
Calx-b domain(s) (Kiyozumi et al., 2007). In addition,
mutations in GRIP1, which encodes a cytoplasmic
scaffolding protein required for proper Fras1 localization at
the BM (Takamiya et al., 2004; Long et al., 2008), result in
classical FS (Vogel et al., 2012). Analysis of the mouse bleb
mutants revealed transient embryonic epidermal blistering,
particularly over the developing eyes and digits, as the likely
primary defect leading to the later malformations
characteristic of the human disorder (McGregor et al., 2003;
Vrontou et al., 2003; Jadeja et al., 2005). The blisters result
from a rupture just beneath the lamina densa of the BM and a
separation of the dermis from the epidermis (McGregor et al.,
2003; Vrontou et al., 2003; Jadeja et al., 2005). Indeed, Fras1,
Frem1, and Frem2 have been shown by immuno-gold
electron microscopy to be localized on the dermal side of
the lamina densa at islands normally associated with
anchoring fibrils (Dalezios et al., 2007; Petrou et al.,
2007a, b). The Fraser complex–associated protein, Frem3,
has a similar ultrastructural localization, which, however, is
independent of Fras1 (Petrou et al., 2007b).
Despite the identification of mutations in FRAS1, FREM2,
and GRIP1 in both mice and humans with FS, a proportion of
human cases remain unresolved, suggesting that other genes
may be involved (van Haelst et al., 2008; Vogel et al., 2012).
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Furthermore, phenotypic variation in FS points to the existence of
common modifier genes (Slavotinek and Tifft, 2002). Mutations
in FREM1 were recently shown to result in bifid nose, renal
agenesis, and anorectal malformations syndrome and Manitoba-
oculo-tricho-anal syndrome, two rare conditions with many
similar phenotypic traits to FS, although milder (Alazami et al.,
2009; Slavotinek et al., 2011). Recent analysis of N-ethyl-N-
nitrosourea-induced mutants in zebrafish (Danio rerio) exhibiting
transient blistering within the developing fins reveals functional
conservation of the FS complex in lower vertebrates and suggests
new potential FS-causing genes, such as hemicentin1 (hmcn1),
encoding a large extracellular matrix protein (Carney et al., 2010)
whose biochemical relationship to the FS complex is unclear.
By means of a biochemical candidate approach in zebrafish
and subsequent analysis in mice, we have identified a, to our
knowledge, previously unreported member of the Fraser
complex, an extracellular matrix protein containing VWA-like
domains related to those in matrilins and collagens (AMACO),
encoded by the VWA2 gene. AMACO (VWA2 protein) is a
member of the von Willebrand factor A (VWA) domain–
containing protein superfamily (Whittaker and Hynes, 2002).
The protein consists of an N-terminal VWA domain, which is
followed by a cysteine-rich domain, an EGF-like domain
carrying elongated O-glucosylated and O-fucosylated glycan
chains, and two more VWA domains. At the C terminus,
another EGF-like domain and a unique domain are present
(Sengle et al., 2003; Gebauer et al., 2008). Analysis of mice
and zebrafish revealed specific AMACO localization at the
BM of multiple tissues during development (Sengle et al.,
2003; Gebauer et al., 2009, 2010). We demonstrate that
AMACO is lost from both zebrafish and mouse mutants that
lack Fras1 and that Fras1 and AMACO interact directly. Finally,
we show that targeted knockdown of AMACO in zebrafish,
which produces no overt phenotype alone, enhances the
phenotype severity of hypomorphic Fras1 mutant zebrafish,
suggesting a supportive role for AMACO in the Fraser complex.
RESULTS
AMACO is reduced or absent in Fras1 mutant zebrafish
It was previously shown that AMACO/vwa2 is expressed during
zebrafish development in a pattern very similar to that of the FS
genes, fras1, frem1a, frem1b, frem2a, frem2b, and frem3
(Carney et al., 2010; Gebauer et al., 2010). We therefore
analyzed AMACO in our panel of Fraser complex and related
mutants: fras1te262/te262, fras1tm95b/tm95b, frem2ata90/ta90,
frem1atc280b/tc280b, and hmcn1tq207/tq207 (Carney et al., 2010).
AMACO and Fras1 are present in the myosepta, the
extracellular boundaries between the somites, and the
developing caudal fin of 32 hours post fertilization (h.p.f.)
wild-type zebrafish (Figure 1a). However, AMACO was com-
pletely lost in null fras1te262/te262 fish (Figure 1b) and strongly
reduced in hypomorphic fras1tm95b/tm95b fish both in immuno-
fluorescence analyses (Figure 1b and c) and immunoblotting
(Figure 1g and h), exactly correlating with Fras1 levels (Figure 1b
and c, inset), whereas vwa2 mRNA levels were unaffected in
fras1 mutant fish (Supplementary Figure S1 online). By contrast,
AMACO and Fras1 levels were normal in frem2ata90/ta90,
frem1atc280b/tc280b, and hmcn1tq207/tq207 fish (Figure 1d–h).
AMACO is absent from Fras1bl/bl mice
Next, we analyzed AMACO in Fras1bl/bl mice. During mouse
development, AMACO is specifically localized at the BMs of
skin, lung, heart, tooth germs, and kidney (Sengle et al., 2003).
Analysis of these regions in E14.5 Fras1bl/bl mice revealed a
complete loss of AMACO from the epidermal BM (Figure 2c)
when compared with wild-type or Fras1þ /bl littermates
(Figure 2a and b) although laminin deposition was normal
(Figure 2d–f). Similarly, analysis of a blistered region over the
eye of a Fras1bl/bl E14.5 embryo revealed a complete lack of
AMACO (Figure 2g) although laminin deposition demon-
strated that a BM was still present, as reported previously
(Figure 2h; Vrontou et al., 2003). Analysis of other regions,
including the eyelid, kidney, and developing tooth germs at
E14.5 also revealed a complete loss of AMACO deposition
(Figure 2i–l and data not shown).
AMACO and Fras1 colocalize beneath the lamina densa
Previous ultrastructural examinations demonstrated that Fras1,
Frem1, Frem2, and AMACO are all localized at the BM zone
(Dalezios et al., 2007; Petrou et al., 2007a, b; Gebauer et al.,
2009). To determine colocalization of Fras1 and AMACO,
double immunoelectron microscopy labeling was performed
on P0 mouse skin using secondary antibodies coupled to
different-sized gold particles. Both proteins were detected in
distinct regions, anchoring plaques, in the dermis close to the
BM (Figure 3a and b). These AMACO and Fras1-positive
patches often occurred where anchoring fibrils fuse
(Figure 3a). Although regions were observed where only one
protein was present, mostly AMACO and Fras1 colocalized
(Figure 3a and b). Collagen VII/Fras1 double immunoelectron
microscopy showed that collagen VII, a major component of
anchoring fibrils, occurs in proximity to Fras1 at anchoring
plaques, but mostly at the opposite side of the plaque,
indicating that the two proteins may not interact directly
(Figure 3c).
The AMACO fragment P2 binds to Fras1 CSPG repeats
To test for direct interactions between AMACO and the Fras1
ectodomain, we used surface plasmon resonance assays. For
AMACO, we generated recombinant full-length protein and
protein fragments corresponding to AMACO domains P1, P2,
and P3 (Figure 4a). Recombinant expression of the full-length
Fras1 ectodomain repeatedly failed (data not shown). To
overcome this problem, Fras1 complementary DNA frag-
ments, representing the VWC-, Furin-like-, CSPG-, and Calx-
b domains and the unique domain alone (Figure 4a), were
cloned for protein production, but only the Furin-like-, CSPG-,
and Calx-b domains were well expressed.
Among these Fras1 fragments, we were only able to
immobilize the CSPG domains on the sensor chip. When
full-length AMACO was injected as soluble analyte at increas-
ing concentrations (0–400 nM) over the CSPG chip, we
obtained association and dissociation curves (Figure 4b),
which could be fitted with a Langmuir 1:1 binding model
and could calculate a dissociation constant (KD) of 75 nM. Of
the three different domains (P1, P2, and P3), binding to
immobilized Fras1 CSPG was only seen with AMACO P2
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(KD 151 nM) (Figure 4b). This binding is independent of the
two unusual glycan chains on AMACO P2, as mutant forms
lacking either one or both glycosylation sites still bound to
immobilized Fras1 CSPG with similar KDs between 77 and
108 nM (data not shown).
In the reverse set up (immobilization of AMACO P2 on the
sensor chip and injection of the Fras1 CSPG), we could
confirm the binding between the AMACO P2 domain and
the Fras1 CSPG domain (KD 42 nM; Figure 4c).
Loss of AMACO does not affect zebrafish development
To analyze the role of AMACO/vwa2 during zebrafish devel-
opment, we generated two translation-inhibiting morpholinos,
which were injected into the yolk of fertilized eggs. Both
morpholinos led to a marked decrease in AMACO protein
levels (Figure 5a and b,), whereas Fras1 appeared largely
normal (Figure 5a and b, insets). Nevertheless, vwa2 mor-
phants exhibited normal morphology both at 48 (Figure 5c
and d) and 80 h.p.f. (Figure 5g and h), including regions that
normally display high AMACO levels (Gebauer et al., 2010)
and that are, at least partly, affected in fras1 mutant zebrafish
(Carney et al., 2010; Talbot et al., 2012), such as the body fins
(Figure 5c and d), the pronephros (data not shown), the
somitic myosepta and their connection to the myotomes
(Figure 5e and f), and the craniofacial cartilage (Figure 5g
and h). This suggests that AMACO per se is dispensable for
early zebrafish development.
Antisense morpholino knockdown of AMACO in Fras1
hypomorphic zebrafish results in a more severe phenotype
The loss of AMACO in Fras1-deficient zebrafish and mice
suggests that Fras1 is required for AMACO deposition or
protein stability. To determine whether AMACO in reverse
stabilizes Fras1 protein and promotes its function, we injected
the vwa2 morpholino into eggs resulting from an in-cross of
fras1þ /tm95b fish (Figure 6). These fish carry the missense
mutation G3816W in Fras1 and exhibit reduced but detect-
able levels of Fras1 protein (Figures 1c and 6b) and are
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Figure 1. AMACO expression is affected in zebrafish models of Fraser syndrome. Immunofluorescence analysis of whole-mount zebrafish at 32 hours post
fertilization (h.p.f.) reveals that (a) AMACO is strongly expressed in the myosepta and developing caudal fin of wild-type zebrafish, very similar to the expression of
Fras1 (inset). (b, c) By contrast, AMACO is completely absent from a zebrafish Fras1 null allele (fras1te262/te262) (b), and partially lost from a hypomorphic Fras1
allele (fras1tm95b/tm95b), which exhibits some residual Fras1 expression (c). (d–f) AMACO expression is normal in null alleles for Frem2a (frem2ata90/ta90; d), Frem1a
(frem1atc280b/tc280b; e), and Hemicentin1 (hmcn1tq207/tq207; f). Expression of Fras1 is also normal in each of these alleles (inset in d–f). Bar¼500mm. (g, h)
Quantitative AMACO immunoblot analysis (Gebauer et al., 2010) in the zebrafish mutants shown in (a–f). In each case, a pool of 50 fish of a given genotype was
extracted to give sufficient material and to minimize the effects of individual variations. In (g), Ponceau loading control is shown. AMACO, extracellular matrix
protein containing VWA-like domains related to those in matrilins and collagens.
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therefore believed to represent a hypomorphic allele. When
an uninjected in-cross of fras1þ /tm95b fish (n¼ 415; 327¼wt,
88¼mut) was compared with an in-cross of fras1þ /te262
(null allele) fish (n¼ 88; 65¼wt, 23¼mut), fras1tm95b/tm95b
fish exhibit a milder caudal fin blistering phenotype as
assessed by morphology (Figure 6a). In addition, injection of
a missense morpholino into an in-cross of fras1þ /tm95b fish
(n¼ 389; 308¼wt, 81¼mut) had no effect on the severity of
the caudal fin blistering phenotype (Figure 6a). Injection of
vwa2 morpholino into an in-cross of fras1þ /tm95b fish
(n¼ 500; 400¼wt, 100¼mut), however, resulted in a more
severe phenotype, which was at a comparable level to that of
null fras1te262/te262 fish (Figure 6a). Representative morpholo-
gies of the caudal fin at 34 h.p.f. for each condition are shown
in Figure 6b. Immunofluorescence analysis of Fras1 revealed
high levels in the myosepta and fin of wild-type fish, reduced
levels in uninjected and missense morpholino-injected
fras1tm95b/tm95b fish, and a complete absence in fras1te262/te262
fish and fras1tm95b/tm95b fish injected with vwa2 morpholino
(Figure 6b), corresponding to the severity of the morphological
phenotype. In contrast, laminin levels were unaltered under
all conditions (Figure 6b).
DISCUSSION
FS is a heterogeneous disorder affecting the development of the
skin, eyes, digits, and kidneys. Although mutations in FRAS1,
FREM2, and GRIP1 have been identified in approximately 95%
of all FS patients, additional genetic contributions to this
disorder remain likely. The highly variable inter- and intra-
familial phenotypic severity of FS also suggests the presence of
genetic modifiers (Slavotinek and Tifft, 2002). In this study, we
have demonstrated that vwa2, a gene encoding AMACO, a BM-
associated extracellular protein containing three VWA domains,
contributes to the Fraser complex in zebrafish and mice.
a WT
AMACO
Laminin
Laminin
Laminin
Laminin
Laminin
Laminin
AMACO AMACO
AMACO AMACO
AMACO
WT
WT
WT
Fras1+/bl
Fras1+/bl
Fras1bl/bl
Fras1bl/bl
Fras1bl/bl
Fras1bl/bl
Fras1bl/bl
Fras1bl/bl
d
g
h
b
e
i
k
c
f
j
l
Figure 2. AMACO expression is lost from Fras1 mutant mice. (a–f) Immunofluorescence analysis of the epidermis of E14.5 wild-type (a, d), Fras1þ /bl (b, e), and
Fras1bl/bl (c, f) littermates reveals a complete loss of AMACO expression from the basement membrane of Fras1bl/bl mice (c), whereas laminin expression
is normal (f). (g–l) Similar analysis of other regions demonstrates the loss of AMACO from a blister over the eye of an E14.5 Fras1bl/bl embryo (g), whereas laminin
expression was still observed under the detached epidermis (j). Strong expression of AMACO was observed surrounding the developing tooth germs of
E14.5 wild-type mice (h) but was completely lost from a Fras1bl/bl littermate (i) despite laminin being normal (k, l). Bars¼ 50mm. For generation and
characterization of the mouse AMACO-P3 antibody, see Gebauer et al., 2009. AMACO, extracellular matrix protein containing VWA-like domains related to those
in matrilins and collagens.
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We could show that AMACO protein is completely absent
in zebrafish and mouse mutants lacking Fras1, suggesting that
Fras1 is crucial for the deposition or stabilization of AMACO.
The vwa2 mRNA expression level in Fras1 mutant zebrafish is,
in contrast, completely normal (Supplementary Figure S1
online), suggesting specific effects on protein stabilization.
Transmission electron microscopy further supports a direct
interaction, as AMACO and Fras1 colocalize at a distance that
is consistent with direct binding in islands beneath the lamina
densa. Unfortunately, a comprehensive study of the interac-
tion between AMACO and Fras1 was hampered by the fact
that the ectodomain, the VWC domains, and the unique
domain of Fras1 could not be recombinantly expressed in
sufficient amounts. However, AMACO fragments covering the
whole sequence were expressed and surface plasmon reso-
nance spectroscopy revealed direct binding between AMACO
P2 and the CSPG domains of Fras1.
Furthermore, we could demonstrate that knockdown of
AMACO, which alone results in no morphological defects,
can increase the phenotypic severity in hypomorphic Fras1
zebrafish. Upon AMACO knockdown, the hypomorphic fish
resemble the complete Fras1 knockout, suggesting that, in
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Figure 3. Fras1 and AMACO colocalize at the basement membrane. For immuno electron microscopy analysis, newborn mouse skin was immunolabeled en bloc
with antibodies directed against mouse AMACO-P3, and mouse Fras1-CSPG (a, b) or human collagen VII and mouse Fras1-CSPG (c). Secondary antibodies
conjugated to gold particles of different size (Fras1: 6 nm; AMACO and collagen VII: 10 nm) were detected at anchoring plaques below the lamina densa (LD,
black arrowheads). Often, anchoring fibrils (AF, open arrowheads) are seen to intersect the anchoring plaques (AP). Collagen VII (arrows) and Fras1 often occur at
opposite sides of anchoring plaques (c). (a, c) Show an overview and (b) shows selected anchoring plaques. The scale bar corresponds to 100 nm in (a, c) and
50 nm in (b). AMACO, extracellular matrix protein containing VWA-like domains related to those in matrilins and collagens; CSPG, chondroitin sulfate
proteoglycan domain.
RJ Richardson et al.
AMACO Is a Mediator of the Fraser Complex
www.jidonline.org 1317
addition to the requirement of Fras1 for AMACO deposition or
stabilization, AMACO can stabilize Fras1. Reciprocal stabili-
zation of Fras1, Frem1, Frem2, and possibly Frem3 has been
revealed in mouse and zebrafish (Kiyozumi et al., 2006;
Carney et al., 2010), whereas zebrafish Hmcn1, despite its
coexpression with the FS genes and the similar phenotype of
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Figure 4. AMACO and Fras1 interact directly. (a) Domain structures of Fras1 and AMACO. S, signal peptide; TM, transmembrane domain; arrow indicates the
furin cleavage site. (b, c) Surface plasmon resonance sensorgrams showing binding of different concentrations of soluble analytes to Fras1 CSPG (b) and AMACO
P2 (c) coupled onto a chip. Full-length AMACO interacts with Fras1 CSPG, as does the AMACO P2 fragment. AMACO P1 and AMACO P3 do not interact (b). In
the reversed orientation, Fras1 CSPG interacts with AMACO P2 (c). All proteins were from mouse. AMACO, extracellular matrix protein containing VWA-like
domains related to those in matrilins and collagens; CSPG, chondroitin sulfate proteoglycan domain.
RJ Richardson et al.
AMACO Is a Mediator of the Fraser Complex
1318 Journal of Investigative Dermatology (2014), Volume 134
hmcn1 and fras1 mutants, is dispensable for Fras1 stabilization
(Carney et al., 2010). Therefore, although loss of AMACO
alone does not cause a tissue integrity phenotype, our results
show that AMACO can also stabilize Fras1 at the BM,
potentially in a manner redundant with other Fraser complex
proteins.
We currently do not know the nature of these potential
redundant factors. For zebrafish Frem2, the Fras1-stabilizing
effect was only revealed upon concomitant knockdown of the
three closely related proteins Frem2a, Frem2b, and Frem3
(Carney et al., 2010). However, AMACO, although being a
member of the VWA domain–containing protein superfamily,
does not belong to a distinct subfamily such as the matrilins or
VWA domain–containing collagens. In addition, no direct
AMACO paralog has been annotated in the zebrafish genome.
Therefore, it seems more likely that AMACO acts in partial
functional redundancy with a more distantly related VWA
protein. Nevertheless, the essential character of AMACO
becomes apparent when Fras1 function is compromised. This
indicates that interactions between several members of the
Fraser complex are required for stabilization beneath the BM,
with AMACO’s function to support this structural complex
becoming vital when the multiprotein structure is compro-
mised by reduced levels or activities of other components.
Owing to these particular genetic features of AMACO and its
physical involvement in the Fraser complex both in zebrafish
and mouse, VWA2 represents an interesting candidate for
human mutation analysis in multigenic scenarios, possibly
mediating a genetic predisposition for FS etiology.
MATERIALS AND METHODS
Zebrafish husbandry
Embryos were obtained from natural crosses and staged according to
Kimmel et al. (1995). The mutant alleles pifte262 (fras1), piftm95(fras1),
neltq207(hmcn1), blata90 (frem2a), and rfltc280b (frem1a) have been
described previously (Carney et al., 2010).
Antisense morpholino knockdown
Morpholino antisense oligonucleotides (Supplementary online) were
designed by and obtained from Gene-Tools (Philomath, OR) and
dissolved in distilled water to obtain 1 mM stock solutions. Two
different morpholinos covering the ATG translation start codon and
the 50 untranslated region of vwa2 were used, both resulting in
translational inhibition. A five-mismatch morpholino was used as
negative control. For injection, stocks were diluted to 0.1 mM in
Danieau’s buffer and phenol red (Nasevicius and Ekker, 2000). A
volume of 0.5 nl of MO solution was injected into embryos at the
1- to 4-cell stage using glass needles pulled on a Sutter needle puller
and a Nanoject injection apparatus (World Precision Instruments,
Berlin, Germany).
Mouse lines
E14.5 mouse embryos, generated from an in-cross of Fras1þ /bl mice
and fixed in 4% paraformaldehyde, were obtained from Peter
Scambler (UCL, London, UK).
Tissue-labeling procedures
For whole-mount immunofluorescence analysis, zebrafish were fixed
in 4% paraformaldehyde overnight at 4 1C and washed with 1
phosphate-buffered saline (PBS). Fish were then washed for several
hours in dH20, blocked in 10% fetal calf serum in 1 PBS and 0.5%
Triton-X, incubated in primary antibody in 10% fetal calf serum
overnight at 4 1C, washed extensively in 1 PBS and 0.5% Triton-X,
incubated overnight in secondary antibody in 10% fetal calf serum at
4 1C, washed extensively in 1 PBS and 0.5% Triton-X, and refixed
in 4% paraformaldehyde. For immunofluorescence analysis on
sections, tissue was dehydrated in a graded series of alcohols, cleared
in Roti-Histol (Carl Roth, Karlsruhe, Germany), and embedded in
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Figure 5. AMACO-deficient zebrafish are phenotypically normal. (a, b) Immunofluorecence analysis with antibodies against the zebrafish proteins (Carney et al.
2010; Gebauer et al., 2010) reveals complete loss of AMACO protein in vwa2 morphant (b), whereas levels of Fras1 are normal (inset in b). (c, d) vwa2 morphants
display normal fin morphology at 48 hours post fertilization (h.p.f.) (e, f) Transmission electron microscopy (TEM) analysis at 48 h.p.f. reveals no defect in the
structure of the myosepta in vwa2 morphants (f) when compared with wild-type controls (e). (g, h) No abnormalities can be observed in the craniofacial cartilage
or general morphology of vwa2 morphants at 80 h.p.f. (h). AMACO, extracellular matrix protein containing VWA-like domains related to those in matrilins and
collagens; Ch, ceratohyal; Hm, hyomandibular; Ih, interhyal; My, myosepta; Pq, palatoquadrate; Sy, symplectic.
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paraffin wax. Immunofluorescence analysis was performed using
standard protocols. The following primary antibodies were used:
rabbit anti-zebrafish AMACO (Gebauer et al., 2010), rabbit anti-
zebrafish Fras1 (Carney et al., 2010), rabbit anti-mouse AMACO
(Gebauer et al., 2009), and rabbit anti-laminin (Sigma Aldrich,
Munich, Germany, L9393). Images were captured on a Zeiss
Axiophot, Zeiss Apotome, Zeiss Confocal (LSM710 META)
(Oberkochen, Germany), or Leica M165 FC compound microscope
(Wetzlar, Germany).
For whole-mount alcian blue stainings, the embryos were washed
in PBS and incubated in 0.1 mg ml–1 alcian blue in ethanol/acetic
acid (4:1) for 2–6 hours at 37 1C. After clearing overnight by digestion
with 50 mg ml–1 trypsin in 30% sodium tetraborate in water, the
specimens were destained in 1% KOH/glycerol, flat-mounted
between a slide and a coverslip, and photographed using a Zeiss
Axiophot microscope equipped with a Nikon digital camera (Du¨ssel-
dorf, Germany). Whole-mount in situ hybridization was performed as
previously described (Gebauer et al., 2010).
Expression of full-length AMACO and Fras1 fragments
Mouse complementary DNA fragments were generated by reverse
transcriptase–PCR and cloned with 5’-terminal NheI and 30-terminal
NotI restriction sites using oligonucleotide primers (Supplementary
Table 1 online). The amplified PCR products were inserted into a
modified pCEP-Pu vector containing an N-terminal BM-40 signal
peptide (Kohfeldt et al., 1997), followed by an N-terminal One-STrEP-
tag (IBA GmbH, Go¨ttingen, Germany) upstream of the restriction
sites. The expression constructs were transfected into 293 EBNA
(Epstein–Barr virus nuclear antigen) cells with FuGENE HD (Roche,
Mannheim, Germany) according to the manufacturer’s instructions.
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Figure 6. vwa2 knockdown in Fras1 hypomorphic zebrafish increases the severity of the phenotype. (a) Chart depicting the relative severity of the blistering
phenotype of Fras1 zebrafish injected with a missense morpholino (5 mm) or a vwa2-specific MO. In all cases, mutant embryos were derived from
heterozygous in-crosses, segregating in a normal Mendelian ratio. Only homozygotes are considered in the chart. Included are representative images of mild,
moderate, and severe blistering. Severe blistering was determined by a large number of caudal fin blisters (arrowheads), often extending further anterior
within the dorsal region of the caudal fin. Associated extensive blistering of the caudal vein region was also observed (arrows). Moderate blistering involved fewer
fin-tip blisters of variable sizes and less, although always some associated caudal vein blistering. Mild blistering was determined by a small number of fin-tip
blisters with no associated caudal vein blistering. Compare with (b) for a representative wild-type fin. (b) Immunolocalization of Fras1 (with zebrafish-specific
antibody, Carney et al., 2010) and laminin for each condition. AMACO, extracellular matrix protein containing VWA-like domains related to those in matrilins and
collagens.
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The cells were cultured in the presence of 10% fetal calf serum before
harvest of cells and cell culture supernatant. After filtration and
centrifugation of supernatants containing recombinant protein for
1 hour at 10,000g, these were applied to a Streptactin column (1.5 ml;
IBA GmbH) and proteins were eluted with 2.5 mM desthiobiotin,
150 mM NaCl, and 100 mM Tris-HCl, pH 8.0.
Fras1 antibody production
Purified mouse Fras1 CSPG was used for guinea pig immunization.
The antiserum was purified by affinity chromatography on a column
with antigen coupled to CNBr-activated Sepharose (Sigma-Aldrich,
C9142). Specific antibodies were eluted with 0.1 M glycine, pH 2.5,
and the eluate was neutralized with 1 M Tris-HCl, pH 8.8. Speci-
ficity was tested by immunoblotting (Supplementary Figure S2
online). The antibody was only used for immunoelectron micro-
scopy.
Surface plasmon resonance binding assays
Binding analyses were performed using a BIAcore2000 (GE Health-
care Europe, Freiburg, Germany). All proteins were from mouse.
Expression and purification of AMACO fragments have been
described earlier (Gebauer et al., 2009), and the purity of the
proteins is documented in (Supplementary Figure S3 online). Fras1
CSPG (2200 RUs), AMACO full-length (2300 RUs), AMACO P1
(2500 RUs), AMACO P2 (2400 RUs), and AMACO P3 (2500 RUs)
were covalently coupled to carboxymethyldextran hydrogel 500 M
sensor chips (XanTec, Du¨sseldorf, Germany) using the amine cou-
pling kit (GE Healthcare). Binding assays were performed at 25 1C in
10 mM Hepes buffer, pH 7.4, containing 0.15 M NaCl, 3 mM EDTA,
and 0.005% (v/v) P20 surfactant. Omission of EDTA and addition of
1 mM MgCl2 and CaCl2 did not result in any change of binding events.
Equilibrium dissociation constants (KD) were then calculated as the
ratio kd/ka. Kinetic constants were calculated by nonlinear fitting
of association and dissociation curves (BIAevaluation 4.1 software,
GE Healthcare Europe).
Protein extraction and immunoblotting
For protein extraction, 32 h.p.f. wild-type and mutant zebrafish larvae
(50 each) were homogenized in 500ml of 150 mM NaCl, 2 mM EDTA,
1% Nonidet P-40, and 50 mM Tris, pH 7.4, and put on ice for
15 minutes. One-third volume of 4 SDS sample buffer (8% (w/v)
SDS, 40% (v/v) glycerol, 0.2% (w/v) bromphenol blue, and 250 mM
Tris-HCl, pH 6.8) was added, the samples boiled for 5 minutes,
centrifuged for 10 minutes, and subjected to nonreducing 4–12%
(w/v) SDS-PAGE. Proteins were transferred to a nitrocellulose
membrane and detected using polyclonal antibodies diluted in
Tris-buffered saline/5% milk powder. Bands were detected by
chemoluminescence immunoassay using a peroxidase-conjugated
swine anti-rabbit secondary antibody (Dako, Hamburg, Germany).
Image J (imagej.nih.gov/ij/download/) was used for quantification
of bands.
Electron microscopy
Wild-type and morphant zebrafish larvae 48 h.p.f. were anesthetized
with 0.08% Tricaine, transferred into 6% glutaraldehyde in 0.1 M
cacodylate buffer, pH 7.2, for immersion fixation, and stored in this
solution for 3 days at 4 1C. Then, the larvae were rinsed 2
15 minutes in 0.1 M cacodylate buffer, pH 7.2, postfixed for
120 minutes with 1% OsO4 in 0.1 M cacodylate buffer, pH 7.2, at
room temperature in the dark, rinsed again, dehydrated with acetone,
and embedded in araldite CY212 (Durcupan ACM, Sigma-Aldrich).
Ultrathin sections were cut at gray interference color (25–30 nm) with
a 351 diamond knife (Diatome, Biel, Switzerland) on an Ultracut E
(Leica), stretched with chloroform vapor, mounted on 200-mesh
copper grids (5mm bar thickness), and contrasted for 10 minutes with
saturated (2%) uranyl acetate in 70% ethanol and for 5 minutes with
0.2% aqueous lead citrate, pH 11.8. Microscopy was performed with
a Zeiss EM109 (80 kV, 500mm condenser 1 aperture, 200mm
condenser 2 aperture, 30mm objective aperture) equipped with a
temperature-stabilized wide-angle YAC-CCD camera at the side entry
port (1024 1024 pixel, 12-bit greyscale/pixel; Albert Tro¨ndle Rest-
lichtversta¨rker Systeme (TRS), Moorenweis, Germany). Magnification
was calibrated with a cross-grating replica (2,160 lines mm–1,
d¼ 0.463mm).
Immunoelectron microscopy
Newborn mouse skin was carefully sliced into 1-mm cubes, all
including the epithelium and the dermis. Tissues were immersed in a
combination of affinity-purified rabbit AMACO-P3 antibody (Gebauer
et al., 2009) or collagen VII antibody (Lunstrum et al., 1986) with
guinea pig Fras1 CSPG antibody (Supplementary Figure S2 online) in
DMEM at a ratio of 1:1:4 overnight at 4 1C. Tissues were washed in
DMEM for 4 hours at 4 1C and then immersed in a combination of
goat anti-rabbit 10-nm and goat anti-guinea pig 6-nm colloidal gold
conjugates in DMEM at a ratio of 1:1:3 overnight at 4 1C. The tissues
were then rinsed extensively in DMEM, fixed in 1.5% glutaraldehyde/
1.5% paraformaldehyde containing 0.5% tannic acid, postfixed in 1%
OsO4, and then dehydrated and embedded in Spurr’s epoxy resin.
Tissue was oriented so that cross-sections of the dermal–epidermal
junction would be obtained. Ultrathin sections were contrasted with
uranyl acetate and lead citrate and examined using a FEI Tecnai G20
TEM (Hillsboro, OR).
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